WEBVTT

1
00:00:04.650 --> 00:00:09.630
<v 0>One of the studies that related to prostate cancer that has really interested me</v>

2
00:00:09.630 --> 00:00:14.040
as a urologist involves the surgical

3
00:00:14.040 --> 00:00:16.950
care of metastatic prostate cancer.

4
00:00:16.950 --> 00:00:21.630
So the standard treatments for metastatic prostate cancer for decades

5
00:00:21.900 --> 00:00:24.450
have been treatments that go to the whole body,

6
00:00:24.690 --> 00:00:29.250
things like androgen deprivation therapy and other medications that can treat

7
00:00:29.250 --> 00:00:33.390
multiple sites of disease. But there are some ongoing trials looking at,

8
00:00:33.390 --> 00:00:38.070
is there a role for surgery in this setting as well.
And

9
00:00:38.400 --> 00:00:42.390
I think probably the most well-known one is called the SW 1802 trial,

10
00:00:42.390 --> 00:00:46.830
or the Southwest Oncology Group Number 1802 trial.

11
00:00:47.400 --> 00:00:52.320
And what they're looking at is for patients who have metastatic prostate cancer,

12
00:00:52.740 --> 00:00:56.340
is getting those kind of standard treatments alone,

13
00:00:56.670 --> 00:01:01.350
or getting one of those standard treatments with the addition of surgery to

14
00:01:01.350 --> 00:01:06.300
remove the prostate where the metastatic disease is kind of stemming from,

15
00:01:06.870 --> 00:01:11.640
is adding surgery beneficial to those patients?
They're also

16
00:01:11.640 --> 00:01:16.470
looking to see if radiation therapy is going to be helpful.

17
00:01:17.490 --> 00:01:22.320
But essentially the crux of this study is the

18
00:01:22.320 --> 00:01:26.940
standard systemic therapy alone versus systemic therapy

19
00:01:26.940 --> 00:01:31.500
with additional treatments to the prostate going to be equivalent or

20
00:01:31.860 --> 00:01:35.400
potentially better with treating the prostate.

21
00:01:35.400 --> 00:01:37.080
And as urologists,

22
00:01:37.320 --> 00:01:41.580
we are the surgical kind of providers really,

23
00:01:41.880 --> 00:01:43.710
who care for prostate cancer. And this is

24
00:01:46.100 --> 00:01:47.160
a great interest, I think,

25
00:01:47.160 --> 00:01:51.960
to a lot of urologists to see if there's a role for us in this disease space

26
00:01:51.960 --> 00:01:55.920
when previously it's really been solely managed by medical

27
00:01:55.920 --> 00:02:00.920
oncologists.